Weekly News

Some of the best medtech innovations come from the simplest concepts, but it all starts by asking the right question first. Whether you agree or not, the week’s timely editorial talks TAVI and questions the concept of the unmet need.

Our weekly medtech news editorial celebrates innovation this time. Maybe in these straitened times fortune favours the brave investor and the best inventor.

Gimme a P, Gimme an M, Gimme an A. What do you get? Well, not quite a PMA, but the end result might look mighty like it by the time it hits the streets. Not a bad thing though, and there’s lots of really sensible and even pragmatic stuff in the new device regs, especially the re-hash of notified body rules.

The week’s medical device news in one piece of editorial. Quite a challenge, so we don’t even try to capture it all. Highlights and opinions in one bite-size package.

Do the recently announced job losses in medtech signifiy some sort of retrenchment or do they represent sensible planning in the run up to the medical device sales tax? Or a bit of both? Either way, there are a number of Americans losing there jobs just about now, which somewhat overshadows the week’s better news. Good news, bad news, all of life is here.

This week’s rant is less of a rant than an attempt to persuade companies of the value of the well written press release.

This week’s View From The Med is ready to read… unless you’re a tired ESC delegate wending your way home after another exhausting bash.

Meandering through the fields of news items that have sprung up this week we pause for reflection on whether product recalls and withdrawals are telling us products are getting to market too easily. We conclude they’re probably not, but we do think we need a bit more regulatory diligence.

Are the summer doldrums a good time to bury bad news or an opportunity to get your story to the top of the editor’s “hmmm interesting” list? We ponder this and other matters in our weekly View From The Med.

News and views from the medtech industry, chewed over and spat out by our resident polemicist when he’s not involved in the Olympics (in a strictly observational capacity you understand)

View From The Med is online now.

Is there enough newsworthy stuff happening in medtech to justify a weekly review? Oh yes.

View From The Med is online right now.

View From The Med Week 28 is our roundup of events from the past seven days. We never cease to be amazed by the amount of new technology we see each week.

Improving success rates after heart attacks, avoiding problems following cataract removal or robotic prostatectomy, improving accuracy in spinal fixation. And more. This week’s View From The Med points to extraordinary advances that we just take for granted.

This week we’re trying to decide whether any little companies have really made it big against their giant cousins, and if not, why not?